Byung-Jin Kwak
Corporate Officer/Principal at Korea Advanced Institute of Science & Technology
Profile
Byung-Jin Kwak is a Professor at Korea Advanced Institute of Science & Technology.
He previously worked as an Auditor at KB No.
3 Special Purpose Acquisition Co. and Sphere Power, Inc. He holds an MBA from The University of Texas at Austin, a Doctorate from Purdue University, and an Undergraduate degree from Seoul National University.
Byung-Jin Kwak active positions
Companies | Position | Start |
---|---|---|
Korea Advanced Institute of Science & Technology | Corporate Officer/Principal | - |
Former positions of Byung-Jin Kwak
Companies | Position | End |
---|---|---|
SPHERE POWER INC. | Comptroller/Controller/Auditor | - |
KB No. 3 Special Purpose Acquistion Co.
KB No. 3 Special Purpose Acquistion Co. Financial ConglomeratesFinance KB No. 3 Special Purpose Acquisition Co. is engaged in the research and development of protein and stem cell medicines. It is also involved in developing cosmetic ingredients and formulations, producing and distributing cosmetics, the disposal of cells and developing medical equipment, researching viruses and developing and distributing medical and skin care devices. The Company was founded on June 25, 2014 and is headquartered at Seoul, South Korea. | Comptroller/Controller/Auditor | - |
Training of Byung-Jin Kwak
Purdue University | Doctorate Degree |
The University of Texas at Austin | Masters Business Admin |
Seoul National University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
SPHERE POWER INC. | Health Technology |
Private companies | 1 |
---|---|
KB No. 3 Special Purpose Acquistion Co.
KB No. 3 Special Purpose Acquistion Co. Financial ConglomeratesFinance KB No. 3 Special Purpose Acquisition Co. is engaged in the research and development of protein and stem cell medicines. It is also involved in developing cosmetic ingredients and formulations, producing and distributing cosmetics, the disposal of cells and developing medical equipment, researching viruses and developing and distributing medical and skin care devices. The Company was founded on June 25, 2014 and is headquartered at Seoul, South Korea. | Finance |
- Stock Market
- Insiders
- Byung-Jin Kwak